Why the Growth of 503B Pharmacies Demands a New Compliance Strategy
The rapid expansion of compounding pharmacies is transforming the way healthcare providers deliver personalized care.
2025 GMP Audit Trends Report: The Most Common Compliance Gaps We’re Seeing Across FDA-Regulated Operations
At VeritasRx, we analyzed 33 GMP, GCP, GDP, and ISO audit engagements conducted between July and November 2025 across five countries and multiple FDA-regulated industries.
How to Choose the Right FDA Expert Witness Firm for Complex Regulatory Matters
Legal disputes involving FDA-regulated products are rarely straightforward. Whether the issue involves pharmaceutical manufacturing, compounding operations, medical devices,
